Skip to main content
Erschienen in: Surgical Endoscopy 9/2008

Open Access 01.09.2008

Timing of cholecystectomy after endoscopic sphincterotomy for common bile duct stones

verfasst von: Anandi H. W. Schiphorst, Marc G. H. Besselink, Djamila Boerma, Robin Timmer, Marinus J. Wiezer, Karel J. van Erpecum, Ivo A. M. J. Broeders, Bert van Ramshorst

Erschienen in: Surgical Endoscopy | Ausgabe 9/2008

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

According to the literature, the conversion rate for laparoscopic cholecystectomy (LC) after endoscopic sphincterotomy (ES) for cholecystodocholithiasis reaches 20%, at least when LC is performed 6 to 8 weeks afterward. It is hypothesized that early planned LC after ES prevents recurrent biliary complications and reduces operative morbidity and hospital stay.

Methods

All consecutive patients who underwent LC after ES between 2001 and 2004 were retrospectively evaluated. Recurrent biliary complications during the waiting time for LC, conversion rate, postoperative complications, and hospital stay were documented.

Results

This study analyzed 167 consecutive patients (59 men) with a median age of 54 years. The median interval between ES and LC was 7 weeks (range, 1–49 weeks). During the waiting time for LC, 33 patients (20%) had recurrent biliary complications including cholecystitis (n = 18, 11%), recurrent choledocholithiasis (n = 9, 5%), cholangitis (n = 4, 2%), and biliary pancreatitis (n = 2, 1%). Of these 33 patients, 15 underwent a second endoscopic retrograde cholangiography (ERC). The median time between ES and the development of recurrent complications was 22 days (range, 3–225 days). Most of the biliary complications (76%) occurred more than 1 week after ES. Conversion to open cholecystectomy occurred for 7 of 33 patients with recurrent complications during the waiting period, compared with 13 of 134 patients with an uncomplicated waiting period (p = 0.14). This concurred with doubled postoperative morbidity (24% vs 11%; p = 0.09) and a longer hospital stay (median, 4 vs 2 days; p < 0.001).

Conclusion

In this retrospective analysis, 20% of all patients had recurrent biliary complications during the waiting period for cholecystectomy after ES. These recurrent complications were associated with a significantly longer hospital stay. Cholecystectomy within 1 week after ES may prevent recurrent biliary complications in the majority of cases and reduce the postoperative hospital stay.
Hinweise
The abstract of this work was presented at the Society of American Gastroendoscopic Suregons (SAGES) 2007 annual meeting in Las Vegas, Nevada, USA.
Of the patients presenting with cholecystolithiasis, 4% to 15% have concomitant common bile duct (CBD) stones [13]. The current standard of treatment for symptomatic CBD stones is endoscopic decompression of the CBD and removal of the stones. Decompression may be achieved by endoscopic sphincterotomy (ES), papillary dilation, nasobiliary drainage, or biliary stenting.
For patients with residual stones in the gallbladder after endoscopic stone removal, the subsequent management of the gallbladder has been subject to debate. Many authors have advocated a wait-and-see policy after ES for these patients because only an estimated 10% of them experience recurrent biliary symptoms in retrospective and nonrandomized studies [48]. However, in two prospective randomized trials, up to 47% of the patients presented with recurrent biliary symptoms after a wait-and-see policy, and the cumulative risk for death was 21% within 5 years (vs 5.8% for patients allocated to planned cholecystectomy) [9, 10].
Single-stage treatment by laparoscopic cholecystectomy (LC) combined with laparoscopic CBD exploration has been introduced as a daring alternative for combined endoscopic and surgical treatment. Despite a recent Cochrane review and a metaanalysis showing comparable results between the two strategies, experience and expertise for the widespread use of laparoscopic CBD exploration still are lacking [11, 12]. Thus, in many countries, patients who undergo ES for CBD-stones are subsequently scheduled for cholecystectomy.
The interval between LC and ES may vary from days to months. In the Netherlands, as in other countries, LC is performed 6 to 9 weeks after ES [9, 10, 1316]. The performance of LC after ES is associated with a higher conversion rate than experienced by patients with uncomplicated cholecystolithiasis [9, 10, 17]. To evaluate the influence of timing of LC after ES for complicated gallstone disease, we retrospectively reviewed a consecutive patient series with an emphasis on the relation between recurrent biliary complications after ES and conversion rate, operative morbidity, and hospital stay.

Materials and methods

This study was performed in a university hospital and a large affiliated teaching hospital. The hospitals’ digital databases were searched for patients who underwent both ES and cholecystectomy for gallstone disease between 1 January 2001 and 1 January 2005.
All consecutive patients who underwent ES and subsequent (planned) cholecystectomy, both in the same hospital, were included. Patients requiring emergency cholecystectomy within 72 h after ES (n = 6) were excluded from this study because it was considered that elective cholecystectomy never had been planned for these patients.
The variables collected included age at time of ES, gender, date and indication of the first ES, recurrent biliary complaints between ES and elective cholecystectomy, readmissions, endoscopic reintervention during the waiting period, date of emergency cholecystectomy, complications of cholecystectomy (bleeding requiring transfusion, bleeding requiring intervention, bile leakage requiring drainage), conversion rate, hospital stay, and mortality rate. The main outcome parameters were the number of patients with biliary complications during the waiting period for cholecystectomy and the outcome of surgery (conversion rate, morbidity, and postoperative hospital stay). Biliary complications were defined as complications attributable to bile stones leading to cholecystitis, obstructive choledocholithiasis, or acute biliary pancreatitis. Patients with a complicated waiting period were compared with patients who had an uncomplicated waiting period in terms of postoperative complications and hospital stay.
Statistical analysis was performed using SPSS for windows (SPSS, Inc., Chicago, IL, USA). Fisher’s exact test and the Mann-Whitney U test were used to compare groups. Statistical significance was defined as a two-tailed p value less than 0.05.

Results

Between 2001 and 2005, 167 consecutive patients (59 men) with a median age of 54 years (range, 18–87 years) underwent ES for symptomatic CBD stones followed by cholecystectomy.

Endoscopic sphincterotomy

Endoscopic retrograde cholangiography (ERC) was performed because of suspected CBD stones based on clinical, laboratory, and ultrasonographic data. For all the studied patients, ES was performed after obstructive choledocholithiasis had been proved on ERC. The findings showed that 34 patients also had biliary pancreatitis and that 18 patients had cholangitis. For 81 patients (49%), stones were extracted from the CBD, and for 50 patients (30%), sludge was evacuated. One patient was treated with a nasobiliary drain, and four patients (2%) had biliary stenting.

Waiting period

The median time between ES and planned LC was 7 weeks (range, 1–49 weeks). During the waiting period, 33 (20%) of 167 patients experienced recurrent biliary complications (Table 1), including 18 patients with acute cholecystitis (11%), 9 with recurrent choledocholithiasis (5%), 4 with cholangitis (2%), and 2 with biliary pancreatitis (1%).
Table 1
Biliary complications in the waiting period between endoscopic sphincterotomy and cholecystectomy
Biliary complication n (%)
 
Leading to this intervention
  
Additional ERCP
Emergency cholecystectomy
Total
33 (20)
16
24
Acute cholecystitis
18 (11)
1
18
Recurrent choledocholithiasis
9 (5)
9
3
Cholangitis
4 (2)
4
2
Biliary pancreatitis
2 (1)
2
1
ERCP, endoscopic retrograde choledochopancreaticography
These biliary complications needed the following interventions: endoscopic reintervention for 16 patients and emergency cholecystectomy for 24 patients (Table 1). The median time until the development of recurrent biliary complaints after ES was 22 days (range, 3–225 days), and 76% of the biliary complications occurred more than 1 week after ES. Age, gender, and the indication for initial ES did not differ between the patients with and those without a complicated waiting period (data not shown).

Cholecystectomy

The surgery for all the patients was performed by surgeons or surgical residents under supervision. Open cholecystectomy was performed primarily for 7 patients (4%) because of a previous colostomy (n = 2), a retained CBD stone (n = 1), diffuse peritonitis (n = 2), pancreatic necrosis (n = 1), or subphrenic abscess (n = 1). For the remaining 160 patients, the overall conversion rate for cholecystectomy was 13%. There was a nonsignificant higher conversion rate for patients with a complicated waiting period (21%, 7/33 vs 10%, 14/134; p = 0.14). The reasons for conversion are listed in Table 2.
Table 2
Reason for conversion of laparoscopic cholecystectomy after endoscopic sphincterotomy for patients with or without a biliary complication during the waiting period
 
Complicated waiting period
Uncomplicated waiting period
p Value
(n = 33) n (%)
(n = 134) n (%)
Reason for conversion
Overall
7 (21)
14 (10)
0.14
Unclear anatomy
4 (12)
5 (4)
 
Adhesions
2 (6)
6 (4)
 
Bleeding
1 (3)
1 (1)
 
CBD lesion
0
1 (1)
 
Technical failure
0
1 (1)
 
CBD, common bile duct

Postoperative course

The overall postoperative morbidity rate was 14%. Patients with a complicated waiting period had a nonsignificant increase in complications and a longer postoperative hospital stay (Table 3). One patient with an uncomplicated waiting period (1%) experienced bile leakage from the cystic duct compared with three patients with a complicated waiting period (9%). All needed endoscopic stenting. One major bile duct injury was experienced by a patient with an uncomplicated waiting period, requiring laparotomy and CBC reconstruction. Six patients experienced postoperative bleeding during the uncomplicated waiting period group compared with no patients in the complicated group. No reasons for this difference could be found. One of these patients experienced hypovolemic shock due to bleeding from the liver bed requiring relaparotomy. Despite packing to control the bleeding, the patient died in the intensive care ward the same day. Mortality was nil in the complicated waiting period group. The median postoperative hospital stay was 2 days in the uncomplicated waiting period group compared with 4 days in the complicated waiting period group (p < 0.001).
Table 3
Postcholecystectomy course of patients with and without a complicated waiting period
 
Complicated waiting period
Uncomplicated waiting period
p Value
(n = 33) n (%)
(n = 134) n (%)
Morbidity and interventions
Overall
8 (24)
15 (11)
0.09
  CBD lesion
0
1 (1)
 
    Bile duct reconstruction
 
1
 
  Cystic duct leakage
3 (9)
1 (1)
 
    Endoscopic stenting
3
1
 
  Abscess
2 (6)
4 (3)
 
    Drainage
1
2
 
  Bleeding
0
6 (4)
 
    Transfusion
 
1
 
    Relaparotomy
 
1
 
  Bowel perforation
1 (3)
0
 
    Relaparotomy
1
  
  Other
2 (6)
3 (2)
 
Median postcholecystectomy hospital stay (days)
4
2
<0.001

Discussion

This study has shown that among patients waiting to undergo cholecystectomy after ES for CBD stones, every fifth patient experiences recurrent biliary events requiring endoscopic reintervention, emergency cholecystectomy, or both. For patients who experienced these recurrent events, the postoperative morbidity, conversion rate, and median postoperative hospital stay were doubled.
The issue of biliary complications recurring in the waiting period for LC and the outcome of surgery were not addressed earlier. Recurrent symptoms and reinterventions not only have an obvious influence on a patient’s well-being, but recurrent symptoms also appear to be associated with increased difficulty of surgery and a more complicated postoperative course. Although conversion to open cholecystectomy is a perioperative problem, it is not regarded as a complication of LC. However, open cholecystectomy is associated with increased postoperative pain, more pulmonary complications and wound infections, and a lengthened hospital stay [1822]. Thus, diminishing the conversion rate by timely surgery after ES seems worthwhile.
In both randomized trials mentioned earlier, a remarkably high conversion rate was found, not only among patients who underwent cholecystectomy on demand (50%), but also among patients allocated to planned LC. In both trials, conversion to open cholecystectomy was necessary for more than 20% of the patients [9, 10]. In contrast, among patients with uncomplicated gallstone disease (i.e., without CBD stones or need for ES), the conversion rate for LC is known to be 3% to 5% [2, 18, 20, 21, 2327].
Possibly, the timing of LC after ES may have an influence on the difficulty of surgery. The median time until cholecystectomy in the current study was 7 weeks. The moment of surgery was largely determined by the surgeon who performed the cholecystectomy. In the Netherlands, LC often is planned 6 weeks after ES, partly due to logistic reasons but also because many surgeons believe that surgery is safer several weeks after ES.
The literature has little data for determining the optimal timing of cholecystectomy after ES. Only one study specifically considers the timing of LC after ES in relation to the conversion rate. A significantly higher conversion rate was encountered when LC was performed 2 to 6 weeks after ES, as compared with 1 week after ES [15]. Reports of LC performed within days after ES show conversion rates as low as those for patients with uncomplicated cholelithiasis [2, 16, 28, 29].
Early cholecystectomy after ES may prevent recurrent biliary complications, which are associated with increased postoperative morbidity and prolonged hospital stay. In the current study, up to 76% of these recurrent events may have been prevented by early cholecystectomy (i.e., within 1 week after ES). Furthermore, timely surgery may decrease the conversion rate. A prospective randomized multicenter trial has been initiated to compare early (within 72 h) and late (after 6–8 weeks) cholecystectomy after ES (LANS-trial, ISRCTN42981144).

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Open AccessThis is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://​creativecommons.​org/​licenses/​by-nc/​2.​0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

© Springer Medizin

Bis 11. April 2024 bestellen und im ersten Jahr 50 % sparen!

Literatur
1.
Zurück zum Zitat Collins C, Maguire D, Ireland A, Fitzgerald E, O’Sullivan GC (2004) A prospective study of common bile duct calculi in patients undergoing laparoscopic cholecystectomy: natural history of choledocholithiasis revisited. Ann Surg 239:28–33PubMedCrossRef Collins C, Maguire D, Ireland A, Fitzgerald E, O’Sullivan GC (2004) A prospective study of common bile duct calculi in patients undergoing laparoscopic cholecystectomy: natural history of choledocholithiasis revisited. Ann Surg 239:28–33PubMedCrossRef
2.
Zurück zum Zitat Sarli L, Iusco DR, Roncoroni L (2003) Preoperative endoscopic sphincterotomy and laparoscopic cholecystectomy for the management of cholecystocholedocholithiasis: 10-year experience. World J Surg 27:180–186PubMed Sarli L, Iusco DR, Roncoroni L (2003) Preoperative endoscopic sphincterotomy and laparoscopic cholecystectomy for the management of cholecystocholedocholithiasis: 10-year experience. World J Surg 27:180–186PubMed
3.
Zurück zum Zitat Joyce WP, Keane R, Burke GJ, Daly M, Drumm J, Egan TJ, Delaney PV (1991) Identification of bile duct stones in patients undergoing laparoscopic cholecystectomy. Br J Surg 78:1174–1176PubMedCrossRef Joyce WP, Keane R, Burke GJ, Daly M, Drumm J, Egan TJ, Delaney PV (1991) Identification of bile duct stones in patients undergoing laparoscopic cholecystectomy. Br J Surg 78:1174–1176PubMedCrossRef
4.
Zurück zum Zitat Hill J, Martin DF, Tweedle DE (1991) Risks of leaving the gallbladder in situ after endoscopic sphincterotomy for bile duct stones. Br J Surg 78:554–557PubMedCrossRef Hill J, Martin DF, Tweedle DE (1991) Risks of leaving the gallbladder in situ after endoscopic sphincterotomy for bile duct stones. Br J Surg 78:554–557PubMedCrossRef
5.
Zurück zum Zitat Lai KH, Lin LF, Lo GH, Cheng JS, Huang RL, Lin CK, Huang JS, Hsu PI, Peng NJ, Ger LP (1999) Does cholecystectomy after endoscopic sphincterotomy prevent the recurrence of biliary complications? Gastrointest Endosc 49:483–487PubMedCrossRef Lai KH, Lin LF, Lo GH, Cheng JS, Huang RL, Lin CK, Huang JS, Hsu PI, Peng NJ, Ger LP (1999) Does cholecystectomy after endoscopic sphincterotomy prevent the recurrence of biliary complications? Gastrointest Endosc 49:483–487PubMedCrossRef
6.
Zurück zum Zitat Hammarstrom LE, Holmin T, Stridbeck H (1996) Endoscopic treatment of bile duct calculi in patients with gallbladder in situ: long-term outcome and factors. Scand J Gastroenterol 31:294–301PubMedCrossRef Hammarstrom LE, Holmin T, Stridbeck H (1996) Endoscopic treatment of bile duct calculi in patients with gallbladder in situ: long-term outcome and factors. Scand J Gastroenterol 31:294–301PubMedCrossRef
7.
Zurück zum Zitat Neoptolemos JP, Carr-Locke DL, Fraser I, Fossard DP (1984) The management of common bile duct calculi by endoscopic sphincterotomy in patients with gallbladders in situ. Br J Surg 71:69–71PubMedCrossRef Neoptolemos JP, Carr-Locke DL, Fraser I, Fossard DP (1984) The management of common bile duct calculi by endoscopic sphincterotomy in patients with gallbladders in situ. Br J Surg 71:69–71PubMedCrossRef
8.
Zurück zum Zitat Welbourn CR, Beckly DE, Eyre-Brook IA (1995) Endoscopic sphincterotomy without cholecystectomy for gall stone pancreatitis. Gut 37:119–120PubMedCrossRef Welbourn CR, Beckly DE, Eyre-Brook IA (1995) Endoscopic sphincterotomy without cholecystectomy for gall stone pancreatitis. Gut 37:119–120PubMedCrossRef
9.
Zurück zum Zitat Lau JY, Leow CK, Fung TM, Suen BY, Yu LM, Lai PB, Lam YH, Ng EK, Lau WY, Chung SS, Sung JJ (2006) Cholecystectomy or gallbladder in situ after endoscopic sphincterotomy and bile duct stone removal in Chinese patients. Gastroenterology 130:96–103PubMedCrossRef Lau JY, Leow CK, Fung TM, Suen BY, Yu LM, Lai PB, Lam YH, Ng EK, Lau WY, Chung SS, Sung JJ (2006) Cholecystectomy or gallbladder in situ after endoscopic sphincterotomy and bile duct stone removal in Chinese patients. Gastroenterology 130:96–103PubMedCrossRef
10.
Zurück zum Zitat Boerma D, Rauws EA, Keulemans YC, Janssen IM, Bolwerk CJ, Timmer R, Boerma EJ, Obertop H, Huibregtse K, Gouma DJ (2002) Wait-and-see policy or laparoscopic cholecystectomy after endoscopic sphincterotomy for bile duct stones: a randomised trial. Lancet 360:761–765PubMedCrossRef Boerma D, Rauws EA, Keulemans YC, Janssen IM, Bolwerk CJ, Timmer R, Boerma EJ, Obertop H, Huibregtse K, Gouma DJ (2002) Wait-and-see policy or laparoscopic cholecystectomy after endoscopic sphincterotomy for bile duct stones: a randomised trial. Lancet 360:761–765PubMedCrossRef
11.
Zurück zum Zitat Martin DJ, Vernon DR, Toouli J (2006) Surgical versus endoscopic treatment of bile duct stones. Cochrane Database Syst Rev CD003327 Martin DJ, Vernon DR, Toouli J (2006) Surgical versus endoscopic treatment of bile duct stones. Cochrane Database Syst Rev CD003327
12.
Zurück zum Zitat Clayton ES, Connor S, Alexakis N, Leandros E (2006) Meta-analysis of endoscopy and surgery versus surgery alone for common bile duct stones with the gallbladder in situ. Br J Surg 93:1185–1191PubMedCrossRef Clayton ES, Connor S, Alexakis N, Leandros E (2006) Meta-analysis of endoscopy and surgery versus surgery alone for common bile duct stones with the gallbladder in situ. Br J Surg 93:1185–1191PubMedCrossRef
13.
Zurück zum Zitat Schachter P, Peleg T, Cohen O (2000) Interval laparoscopic cholecystectomy in the management of acute biliary pancreatitis. HPB Surg 11:319–322, discussion 322–313PubMedCrossRef Schachter P, Peleg T, Cohen O (2000) Interval laparoscopic cholecystectomy in the management of acute biliary pancreatitis. HPB Surg 11:319–322, discussion 322–313PubMedCrossRef
14.
Zurück zum Zitat Cameron DR, Goodman AJ (2004) Delayed cholecystectomy for gallstone pancreatitis: readmissions and outcomes. Ann R Coll Surg Engl 86:358–362PubMedCrossRef Cameron DR, Goodman AJ (2004) Delayed cholecystectomy for gallstone pancreatitis: readmissions and outcomes. Ann R Coll Surg Engl 86:358–362PubMedCrossRef
15.
Zurück zum Zitat de Vries A, Donkervoort SC, van Geloven AA, Pierik EG (2005) Conversion rate of laparoscopic cholecystectomy after endoscopic retrograde cholangiography in the treatment of choledocholithiasis: does the time interval matter? Surg Endosc 19:996–1001PubMedCrossRef de Vries A, Donkervoort SC, van Geloven AA, Pierik EG (2005) Conversion rate of laparoscopic cholecystectomy after endoscopic retrograde cholangiography in the treatment of choledocholithiasis: does the time interval matter? Surg Endosc 19:996–1001PubMedCrossRef
16.
Zurück zum Zitat Hamy A, Hennekinne S, Pessaux P, Lada P, Randriamananjo S, Lermite E, Boyer J, Arnaud JP (2003) Endoscopic sphincterotomy prior to laparoscopic cholecystectomy for the treatment of cholelithiasis. Surg Endosc 17:872–875PubMedCrossRef Hamy A, Hennekinne S, Pessaux P, Lada P, Randriamananjo S, Lermite E, Boyer J, Arnaud JP (2003) Endoscopic sphincterotomy prior to laparoscopic cholecystectomy for the treatment of cholelithiasis. Surg Endosc 17:872–875PubMedCrossRef
17.
Zurück zum Zitat Allen NL, Leeth RR, Finan KR, Tishler DS, Vickers SM, Wilcox CM, Hawn MT (2006) Outcomes of cholecystectomy after endoscopic sphincterotomy for choledocholithiasis. J Gastrointest Surg 10:292–296PubMedCrossRef Allen NL, Leeth RR, Finan KR, Tishler DS, Vickers SM, Wilcox CM, Hawn MT (2006) Outcomes of cholecystectomy after endoscopic sphincterotomy for choledocholithiasis. J Gastrointest Surg 10:292–296PubMedCrossRef
18.
Zurück zum Zitat Berggren U, Gordh T, Grama D, Haglund U, Rastad J, Arvidsson D (1994) Laparoscopic versus open cholecystectomy: hospitalization, sick leave, analgesia, and trauma responses. Br J Surg 81:1362–1365PubMedCrossRef Berggren U, Gordh T, Grama D, Haglund U, Rastad J, Arvidsson D (1994) Laparoscopic versus open cholecystectomy: hospitalization, sick leave, analgesia, and trauma responses. Br J Surg 81:1362–1365PubMedCrossRef
19.
Zurück zum Zitat Dirksen CD, Schmitz RF, Hans KM, Nieman FH, Hoogenboom LJ, Go PM (2001) Ambulatory laparoscopic cholecystectomy is as effective as hospitalization and from a social perspective less expensive: a randomized study. Ned Tijdschr Geneeskd 145:2434–2439PubMed Dirksen CD, Schmitz RF, Hans KM, Nieman FH, Hoogenboom LJ, Go PM (2001) Ambulatory laparoscopic cholecystectomy is as effective as hospitalization and from a social perspective less expensive: a randomized study. Ned Tijdschr Geneeskd 145:2434–2439PubMed
20.
Zurück zum Zitat Hasukic S, Mesic D, Dizdarevic E, Keser D, Hadziselimovic S, Bazardzanovic M (2002) Pulmonary function after laparoscopic and open cholecystectomy. Surg Endosc 16:163–165PubMedCrossRef Hasukic S, Mesic D, Dizdarevic E, Keser D, Hadziselimovic S, Bazardzanovic M (2002) Pulmonary function after laparoscopic and open cholecystectomy. Surg Endosc 16:163–165PubMedCrossRef
21.
Zurück zum Zitat Hendolin HI, Paakonen ME, Alhava EM, Tarvainen R, Kemppinen T, Lahtinen P (2000) Laparoscopic or open cholecystectomy: a prospective randomised trial to compare postoperative pain, pulmonary function, and stress response. Eur J Surg 166:394–399PubMedCrossRef Hendolin HI, Paakonen ME, Alhava EM, Tarvainen R, Kemppinen T, Lahtinen P (2000) Laparoscopic or open cholecystectomy: a prospective randomised trial to compare postoperative pain, pulmonary function, and stress response. Eur J Surg 166:394–399PubMedCrossRef
22.
Zurück zum Zitat Neugebauer E, Troidl H, Spangenberger W, Dietrich A, Lefering R (1991) Conventional versus laparoscopic cholecystectomy and the randomized controlled trial. Cholecystectomy Study Group. Br J Surg 78:150–154PubMedCrossRef Neugebauer E, Troidl H, Spangenberger W, Dietrich A, Lefering R (1991) Conventional versus laparoscopic cholecystectomy and the randomized controlled trial. Cholecystectomy Study Group. Br J Surg 78:150–154PubMedCrossRef
23.
Zurück zum Zitat Knight JS, Mercer SJ, Somers SS, Walters AM, Sadek SA, Toh SK (2004) Timing of urgent laparoscopic cholecystectomy does not influence conversion rate. Br J Surg 91:601–604PubMedCrossRef Knight JS, Mercer SJ, Somers SS, Walters AM, Sadek SA, Toh SK (2004) Timing of urgent laparoscopic cholecystectomy does not influence conversion rate. Br J Surg 91:601–604PubMedCrossRef
24.
Zurück zum Zitat Jones K, DeCamp BS, Mangram AJ, Dunn EL (2005) Laparoscopic converted to open cholecystectomy minimally prolongs hospitalization. Am J Surg 190:879–881PubMed Jones K, DeCamp BS, Mangram AJ, Dunn EL (2005) Laparoscopic converted to open cholecystectomy minimally prolongs hospitalization. Am J Surg 190:879–881PubMed
25.
Zurück zum Zitat McMahon AJ, Russell IT, Ramsay G, Sunderland G, Baxter JN, Anderson JR, Galloway D, O’Dwyer PJ (1994) Laparoscopic and minilaparotomy cholecystectomy: a randomized trial comparing postoperative pain and pulmonary function. Surgery 115:533–539PubMed McMahon AJ, Russell IT, Ramsay G, Sunderland G, Baxter JN, Anderson JR, Galloway D, O’Dwyer PJ (1994) Laparoscopic and minilaparotomy cholecystectomy: a randomized trial comparing postoperative pain and pulmonary function. Surgery 115:533–539PubMed
26.
Zurück zum Zitat Ros A, Gustafsson L, Krook H, Nordgren CE, Thorell A, Wallin G, Nilsson E (2001) Laparoscopic cholecystectomy versus minilaparotomy cholecystectomy: a prospective, randomized, single-blind study. Ann Surg 234:741–749PubMedCrossRef Ros A, Gustafsson L, Krook H, Nordgren CE, Thorell A, Wallin G, Nilsson E (2001) Laparoscopic cholecystectomy versus minilaparotomy cholecystectomy: a prospective, randomized, single-blind study. Ann Surg 234:741–749PubMedCrossRef
27.
Zurück zum Zitat Barkun JS, Barkun AN, Sampalis JS, Fried G, Taylor B, Wexler MJ, Goresky CA, Meakins JL (1992) Randomised controlled trial of laparoscopic versus mini cholecystectomy. The McGill Gallstone Treatment Group. Lancet 340:1116–1119PubMedCrossRef Barkun JS, Barkun AN, Sampalis JS, Fried G, Taylor B, Wexler MJ, Goresky CA, Meakins JL (1992) Randomised controlled trial of laparoscopic versus mini cholecystectomy. The McGill Gallstone Treatment Group. Lancet 340:1116–1119PubMedCrossRef
28.
Zurück zum Zitat Sand J, Airo I, Hiltunen KM, Mattila J, Nordback I (1992) Changes in biliary bacteria after endoscopic cholangiography and sphincterotomy. Am Surg 58:324–328PubMed Sand J, Airo I, Hiltunen KM, Mattila J, Nordback I (1992) Changes in biliary bacteria after endoscopic cholangiography and sphincterotomy. Am Surg 58:324–328PubMed
29.
Zurück zum Zitat Sarli L, Iusco D, Sgobba G, Roncoroni L (2002) Gallstone cholangitis: a 10-year experience of combined endoscopic and laparoscopic treatment. Surg Endosc 16:975–980PubMedCrossRef Sarli L, Iusco D, Sgobba G, Roncoroni L (2002) Gallstone cholangitis: a 10-year experience of combined endoscopic and laparoscopic treatment. Surg Endosc 16:975–980PubMedCrossRef
Metadaten
Titel
Timing of cholecystectomy after endoscopic sphincterotomy for common bile duct stones
verfasst von
Anandi H. W. Schiphorst
Marc G. H. Besselink
Djamila Boerma
Robin Timmer
Marinus J. Wiezer
Karel J. van Erpecum
Ivo A. M. J. Broeders
Bert van Ramshorst
Publikationsdatum
01.09.2008
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 9/2008
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-008-9764-8

Weitere Artikel der Ausgabe 9/2008

Surgical Endoscopy 9/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.